Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

University of Zurich

🇨🇭Switzerland

Country: 🇨🇭Switzerland

Ownership: Private

Established: 1833-04-29

Employees: 5K

Market Cap: -

Website: http://www.uzh.ch

Clinical Trials

Adjuvant Versus Neoadjuvant Plus Adjuvant Chemotherapy in Resectable Pancreatic Cancer

Phase 3

Terminated

Conditions: Pancreatic Cancer

Interventions: Drug: Neoadjuvant Chemotherapy with gemcitabine/oxaliplatin
Drug: adjuvant chemotherapy with gemcitabine

First Posted Date: 2011-03-14

Last Posted Date: 2019-07-25

Lead Sponsor: University of Zurich

Target Recruit Count: 38

Registration Number: NCT01314027

Locations: 🇧🇪
University Hospital of Gent, Gent, Belgium
🇫🇷
University Hospital of Marseille, Marseille, France
🇫🇷
University Hospital of Strasbourg, Strasbourg, France

and more 2 locations

Lymphoma in the Orbit

Conditions: Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma

First Posted Date: 2011-02-24

Last Posted Date: 2011-11-04

Lead Sponsor: University of Zurich

Target Recruit Count: 50

Registration Number: NCT01302912

Locations: 🇨🇭
University Hospital Zurich, Ophthalmic Clinic, Zurich, ZH, Switzerland

Canakinumab for Pyoderma Gangrenosum

Phase 2

Completed

Conditions: Pyoderma Gangrenosum

Interventions: Drug: Canakinumab

First Posted Date: 2011-02-24

Last Posted Date: 2016-09-27

Lead Sponsor: University of Zurich

Target Recruit Count: 5

Registration Number: NCT01302795

Locations: 🇨🇭
Department of Dermatology, University Hospital Zurich, Zurich, Switzerland

Reproducibility of RNFL Circle Scans With ART-Function of Heidelberg Spectralis SD-OCT Software Version 5.3

Conditions: Glaucoma Patients and Healthy Controls

Interventions: Device: Spectralis® SD-OCT, Heidelberg Engineering GmbH, H

First Posted Date: 2011-02-18

Last Posted Date: 2015-01-06

Lead Sponsor: University of Zurich

Target Recruit Count: 100

Registration Number: NCT01299233

Locations: 🇨🇭
University Hospital Zurich, Ophthalmic Clinic, Zurich, ZH, Switzerland

Investigation of Serotonin Neurotransmission in MDMA Users Using Combinated Dexfenfluramine Challenge and PET Imaging

Not Applicable

Completed

Conditions: Amphetamine-Related Disorders
Amphetamine Abuse

Interventions: Drug: dexfenfluramine

First Posted Date: 2011-02-15

Last Posted Date: 2011-12-15

Lead Sponsor: University of Zurich

Target Recruit Count: 50

Registration Number: NCT01296802

Locations: 🇨🇭
University Hospital of Psychiatry Zurich, Zurich, ZH, Switzerland

Choroidal Thickness in Glaucoma Patients and Healthy Controls

Conditions: Glaucoma Patients and Healthy Controls

Interventions: Device: Spectralis® SD-OCT, Heidelberg Engineering GmbH, H

First Posted Date: 2011-02-10

Last Posted Date: 2015-01-06

Lead Sponsor: University of Zurich

Target Recruit Count: 200

Registration Number: NCT01293474

Locations: 🇨🇭
University Hospital Zurich, Ophthalmic Clinic, Zurich, ZH, Switzerland

Lower Urinary Tract Dysfunction Database

Recruiting

Conditions: Neurogenic Bladder
Diseases of the Lower Urinary Tract: General Conditions

First Posted Date: 2011-02-10

Last Posted Date: 2025-04-03

Lead Sponsor: University of Zurich

Target Recruit Count: 7000

Registration Number: NCT01293110

Locations: 🇨🇭
Spinal Cord Injury Center & Research, University of Zürich, Balgrist University Hospital, Zürich, Switzerland

Effect of TNF-Inhibition Combined With Conventional DMARDs on Cervical Pannus in Patients With RA and Cervical Spine Involvement

Conditions: Rheumatoid Arthritis

First Posted Date: 2011-02-09

Last Posted Date: 2012-02-24

Lead Sponsor: University of Zurich

Target Recruit Count: 15

Registration Number: NCT01292616

Locations: 🇨🇭
University Hospital Zurich, Division of Rheumatology, Zurich, ZH, Switzerland

Evaluation of Filtering Blebs Using the "Wuerzburg Bleb Classification Score" Compared to Other Clinical Findings, e.g. the Intraocular Pressure (IOP)

Completed

Conditions: Glaucoma

First Posted Date: 2011-02-01

Last Posted Date: 2011-11-04

Lead Sponsor: University of Zurich

Target Recruit Count: 100

Registration Number: NCT01287442

Locations: 🇨🇭
University Hospital Zurich, Ophthalmic Clinic, Zurich, ZH, Switzerland

Cosmesis and Body Image After Single Port or 4-Port Laparoscopic Cholecystectomy

Not Applicable

Conditions: Symptomatic Gallstone Disease

Interventions: Device: Single Port Cholecystectomy
Device: 4 Port Cholecystectomy

First Posted Date: 2011-01-17

Last Posted Date: 2011-01-17

Lead Sponsor: University of Zurich

Target Recruit Count: 110

Registration Number: NCT01278472

Locations: 🇨🇭
University Hospital Zurich, Division of Visceral and Transplantation Surgery, Zurich, Switzerland

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy